Genome-Wide Association Study of Susceptibility Loci for Radiation-Induced Brain Injury
Overview
Authors
Affiliations
Background: Radiation-induced brain injury is a nonnegligible issue in the management of cancer patients treated by partial or whole brain irradiation. In particular, temporal lobe injury (TLI), a deleterious late complication in nasopharyngeal carcinoma, greatly affects the long-term life quality of these patients. Although genome-wide association studies (GWASs) have successfully identified single nucleotide polymorphisms (SNPs) associated with radiation toxicity, genetic variants contributing to the radiation-induced brain injury have not yet been assessed.
Methods: We recruited and performed follow-up for a prospective observational cohort, Genetic Architecture of Radiotherapy Toxicity and Prognosis, using magnetic resonance imaging for TLI diagnosis. We conducted genome-wide association analysis in 1082 patients and validated the top associations in two independent cohorts of 1119 and 741 patients, respectively. All statistical tests were two-sided.
Results: We identified a promoter variant rs17111237 (A > G, minor allele frequency [MAF] = 0.14) in CEP128 associated with TLI risk (hazard ratio = 1.45, 95% confidence interval = 1.26 to 1.66, Pcombined=3.18 × 10-7) which is in moderate linkage disequilibrium (LD) with rs162171 (MAF = 0.18, R2 = 0.69), the top signal in CEP128 (hazard ratio = 1.46, 95% confidence interval = 1.29-1.66, Pcombined= 6.17 × 10-9). Combining the clinical variables with the top SNP, we divided the patients into different subgroups with varying risk with 5-year TLI-free rates ranging from 33.7% to 95.5%. CEP128, a key component of mother centriole, tightly interacts with multiple radiation-resistant genes and plays an important role in maintaining the functional cilia, which otherwise will lead to a malfunction of the neural network. We found that A > G alteration at rs17111237 impaired the promoter activity of CEP128 and knockdown of CEP128 decreased the clonogenic cell survival of U87 cells under radiation. Noteworthy, 12.7% (27/212) of the GWAS-based associated genes (P < .001) were enriched in the neurogenesis pathway.
Conclusions: This three-stage study is the first GWAS of radiation-induced brain injury that implicates the genetic susceptibility gene CEP128 involved in TLI development and provides the novel insight into the underlying mechanisms of radiation-induced brain injury.
Radiation-Induced Brain Injury: Mechanistic Insights and the Promise of Gut-Brain Axis Therapies.
Li M, Tong F, Wu B, Dong X Brain Sci. 2025; 14(12.
PMID: 39766494 PMC: 11674909. DOI: 10.3390/brainsci14121295.
Jin J, Guo S, Liu L, Wen D, Liu R, Lin J BMC Cancer. 2024; 24(1):1223.
PMID: 39358733 PMC: 11447939. DOI: 10.1186/s12885-024-12966-4.
Phuong C, Qiu B, Mueller S, Braunstein S J Natl Cancer Cent. 2024; 3(2):141-149.
PMID: 39035723 PMC: 11256719. DOI: 10.1016/j.jncc.2023.03.001.
Hou J, He Y, Li H, Ai Z, Lu Q, Zeng B Radiat Oncol. 2024; 19(1):9.
PMID: 38243277 PMC: 10797916. DOI: 10.1186/s13014-024-02400-1.
OuYang P, Zhang B, Guo J, Liu J, Li J, Peng Q EClinicalMedicine. 2023; 58:101930.
PMID: 37090437 PMC: 10114519. DOI: 10.1016/j.eclinm.2023.101930.